Coverage of VIV is thinner than for large U.S. telecoms, and the aggregate is shaped by a small number of named targets. Four identifiable, current analyst price targets were reviewed: Barclays at $14 (Equal Weight, lowered from $16 in late October 2026), Morgan Stanley at $14 (Equal Weight, lowered from $15), Scotiabank at $15.40 (Sector Perform), and Goldman Sachs at $13.90 (Sell, initiated in May 2026). Their arithmetic mean is about $14.30, which rounds to a central target of $14. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The low-to-high range of $13.90 to $15.40 is relatively narrow for a telecom, but the tone is notably cautious: no firm among these carries a Buy rating, and Bank of America upgraded the stock only to a neutral Hold in October 2026. Broader aggregators show wider spreads — some report highs near $18 to $20 and lows near $12 — reflecting older, non-current estimates. The analyst consensus, in short, sees modest upside but stops short of enthusiasm.
At a latest verified close near $11.61, reaching $14 would require a gain of roughly 20%, a substantial move for an established dividend-paying telecom. The path would likely depend on a re-rating alongside earnings delivery: VIV has missed consensus EPS in several recent quarters, including a Q2 2026 miss of $0.19 against expectations near $0.23. Third-quarter results, expected to show EPS near $0.24 on revenue of about $3.10 billion, will be an early test of whether growth is re-accelerating.
The stock trades near the lower end of its 52-week range, having declined from levels above $16 to roughly $11.60. That leaves a wide gap to the $14 target, with little established resistance in between but also a weakened long-term uptrend. The psychologically significant $12 area sits just above the current price as the first hurdle, while prior support near $11 could define downside risk if selling resumes. From what I see, monitoring these levels closely helps clarify the setup.
Most analyst price targets reflect a research horizon of roughly 12 months, though exact horizons vary by firm. Near-term catalysts include the Q3 earnings release and guidance, any further analyst consensus revisions (which have trended lower), Brazilian inflation and central-bank rate decisions, movements in the real, and fiber and mobile subscriber trends. A stabilization or improvement in EPS estimates would be the clearest signal that the stock's direction is turning.
The question of whether VIV can reach $14 hinges on a roughly 20% recovery from current levels. The target is grounded in a small set of cautious analyst estimates, and the supporting case — fiber and 5G growth, margin expansion, and a reliable dividend — is real. But the obstacles are equally tangible: repeated earnings misses, stiff competition, and exposure to the Brazilian real and interest rates. With no Buy ratings among the named analysts and targets clustered just above the current price, the central view is one of guarded optimism rather than conviction. Investors should watch earnings delivery and estimate revisions closely before drawing conclusions about the path toward the target.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on shifting market conditions, technical behavior, and AI-driven analysis. The tool is designed to help traders discover opportunities, monitor existing positions, and spot changing trends more efficiently than manual screening allows. For those looking to streamline their research process, the AI Daily Buy/Sell Signals offer a practical way to track evolving setups. I find it helpful to cross-reference signals with the latest earnings data when evaluating names like VIV.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
VIV saw its Momentum Indicator move above the 0 level on November 09, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 84 similar instances where the indicator turned positive. In 63 of the 84 cases, the stock moved higher in the following days. The odds of a move higher are at 75%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where VIV's RSI Indicator exited the oversold zone, 11 of 18 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 61%.
Following a +2.01% 3-day Advance, the price is estimated to grow further. Considering data from situations where VIV advanced for three days, in 232 of 331 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
VIV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The Moving Average Convergence Divergence Histogram (MACD) for VIV turned negative on October 26, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 32 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 63%.
VIV moved below its 50-day moving average on October 26, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for VIV crossed bearishly below the 50-day moving average on November 03, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 56%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VIV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 57%.
The Tickeron Profit vs. Risk Rating rating for this company is 41 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock slightly better than average.
The Tickeron Valuation Rating of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.278) is normal, around the industry mean (2.292). P/E Ratio (2.785) is within average values for comparable stocks, (-7.252). Projected Growth (PEG Ratio) (0.800) is also within normal values, averaging (8.005). Dividend Yield (0.018) settles around the average of (0.133) among similar stocks. P/S Ratio (1.577) is also within normal values, averaging (5.777).
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating fairly steady price growth. VIV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 70 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of wired telecommunications services
Industry MajorTelecommunications